Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.
Droby A, Yoffe-Vasiliev A, Atias D, Fraser KB, Mabrouk OS, Omer N, Bar-Shira A, Gana-Weisz M, Goldstein O, Artzi M, Ben Bashat D, Alcalay RN, Orr-Urtreger A, Shirvan JC, Cedarbaum JM, Giladi N, Mirelman A, Thaler A. Droby A, et al. Among authors: mabrouk os. NPJ Parkinsons Dis. 2025 Jan 3;11(1):7. doi: 10.1038/s41531-024-00854-4. NPJ Parkinsons Dis. 2025. PMID: 39753572 Free PMC article.
Novel method for detection of UBE3A protein in CSF from individuals with Angelman syndrome.
Mabrouk OS, Comfort Harris NT, Komorowski RW, Fraser K, Berry-Kravis E, Shen MD, Bird LM, Tan WH, Carson RP, Heimer G, Amaral B, Crean R, Dillon GM, Gilbert JP, Holmberg KH, Zhang H, Hubbard S, Shomo AA, Kapadnis U, Traube-Childs A, Graham DL, Koirala S, Nguyen V. Mabrouk OS, et al. Mol Genet Metab. 2025 Jul;145(3):109132. doi: 10.1016/j.ymgme.2025.109132. Epub 2025 May 2. Mol Genet Metab. 2025. PMID: 40411957
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease.
Jennings D, Huntwork-Rodriguez S, Vissers MFJM, Daryani VM, Diaz D, Goo MS, Chen JJ, Maciuca R, Fraser K, Mabrouk OS, van de Wetering de Rooij J, Heuberger JAAC, Groeneveld GJ, Borin MT, Cruz-Herranz A, Graham D, Scearce-Levie K, De Vicente J, Henry AG, Chin P, Ho C, Troyer MD. Jennings D, et al. Among authors: mabrouk os. Mov Disord. 2023 Mar;38(3):386-398. doi: 10.1002/mds.29297. Epub 2023 Feb 18. Mov Disord. 2023. PMID: 36807624 Clinical Trial.
Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, Goldstein O, Kestenbaum M, Cedarbaum JM, Mabrouk OS, Fraser KB, Shirvan JC, Orr-Urtreger A, Mirelman A, Thaler A. Omer N, et al. Among authors: mabrouk os. Mov Disord. 2022 Mar;37(3):651-652. doi: 10.1002/mds.28929. Epub 2022 Jan 22. Mov Disord. 2022. PMID: 35064687 No abstract available.
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, Goldstein O, Kestenbaum M, Cedarbaum JM, Mabrouk OS, Fraser KB, Shirvan JC, Orr-Urtreger A, Mirelman A, Thaler A. Omer N, et al. Among authors: mabrouk os. Mov Disord. 2022 Jan;37(1):190-195. doi: 10.1002/mds.28792. Epub 2021 Sep 22. Mov Disord. 2022. PMID: 34550621 Free PMC article.
In vivo detection of optically-evoked opioid peptide release.
Al-Hasani R, Wong JT, Mabrouk OS, McCall JG, Schmitz GP, Porter-Stransky KA, Aragona BJ, Kennedy RT, Bruchas MR. Al-Hasani R, et al. Among authors: mabrouk os. Elife. 2018 Sep 3;7:e36520. doi: 10.7554/eLife.36520. Elife. 2018. PMID: 30175957 Free PMC article.
48 results